Skip to content
Companies

Altis Biosystems

Human gut tissue models for drug testing

Raised to date

$2.1M

of $2.3M offered across 1 Form D filing

Still open
$124K
Investors
9
Last filed
Apr 7, 2025

About

Altis Biosystems, Inc. is a pioneering biotechnology firm based in North Carolina, dedicated to enhancing preclinical research through the development of innovative human cell-based models that accurately replicate the gastrointestinal (GI) tract. By providing superior alternatives to traditional cell line and animal models, Altis facilitates improved drug discovery and development, ensuring better predictive insights and reducing reliance on animal testing.

The company stands out by offering a unique biobank of stem cells from diverse human donors, allowing for highly customizable research that addresses patient-specific treatment variations.

Funding

  • EquityFiled Apr 7, 2025Form D
    $2.1M/ $2.3M

Product

RepliGut® System

In Vitro Models

The RepliGut® System is a groundbreaking collection of in vitro models derived from human intestinal stem cells that replicate the structure and function of the human intestine. It is designed to advance preclinical research by providing more human-relevant data for drug efficacy, toxicity, and bioavailability assessments.

  • RepliGut® Planar for drug-induced toxicity and permeability assays
  • RepliGut® Crypt to model intestinal crypt cell development
  • RepliGut® Kits for customized experimental setup with essential materials included

Built for

Pharmaceutical, Biotechnology, and Life Sciences

People on file